Price Target: EUR (35.00)

Similar documents
Borussia Dortmund GmbH & Co KGaA

Price Target: EUR (50.00)

Price Target: EUR (20.00) 04 April 2012 FY11 results: No surprises so far

Price Target: EUR 1.30 (1.30)

Price Target: EUR 4.15 (3.80)

Price Target: EUR (22.00)

Price Target: EUR 1.60 (1.50)

Borussia Dortmund GmbH & Co KGaA

Price target: EUR (20.00) 15 August 2014 Final 2Q figures match preliminary figures

Borussia Dortmund GmbH & Co. KGaA

Borussia Dortmund GmbH & Co KGaA

Price Target: EUR (17.00)

Price Target: EUR 5.00 (5.00)

Price Target: EUR (20.60) 07 April 2011 Solid FY10 & More to come

Solid preliminary FY 2014 results released. Net asset value increased by 3.5% in H 2014 with difficult trading environment

Borussia Dortmund GmbH & Co. KGaA

Price Target: EUR (19.00)

Borussia Dortmund GmbH & Co. KGaA

PrimeCity Investment Plc

BUY (previous: BUY) (previous: 77.50)

NOT RATED. (previously Buy) (previously 1.73) adj. net (mln ) DPS ( ) adj. EPS ( )

PA Power Automation AG

Evaluation result Fair value DPS. adj. net. adj. EPS ( )

Electronics Line 3000 Ltd.

PA Power Automation AG

ISRA VISION Neutral

Key ratios Sales adj. net

HOLD 51,85. (previous: Hold) (previous: 51,65)

TEMPORARILY NO VALUATION. (previous: not rated)

Buy PT EUR24,00, upside 23%

HOLD (previous: BUY) (previous: 68.00)

Financials/Prime Standard

Reduced EPS but smart acquisition

Research Note. Fair Value REIT-AG

CLERE AG DELISTING & TAKEOVER BID BY MAIN SHAREHOLDER. FIRST BERLIN Equity Research. Delisting & PRICE TARGET C L

Strong growth ahead QUIRIN PRIVATBANK EQUITY RESEARCH. 18 Mai 2017 EQS Group AG

BUY (previous: BUY) (previous: 3.70)

QUIRIN PRIVATBANK EQUITY RESEARCH

HOLD (previous: Hold) (previous: 51.85)

Evaluation Result Fair Value BUY (previous: BUY) (previous: 65.50)

Evaluation result Fair value BUY (prev.: BUY) (prev.: 21.52)

Klaus Kränzle, Please inform yourself of important disclosures and disclaimers in the appendix

SFC Energy AG STRONG GROWTH AND PROFITABILITY AHEAD. FIRST BERLIN Equity Research. Preliminary PRICE TARGET S F

BUY (previous: BUY) (previous: 72.30) DPS ( ) adj. EPS ( )

- 2/7 - Segment Discussion August 05, Segment Discussion. Stock and Valuation

13 May 2016 PNE WIND AG. FIRST BERLIN Equity Research

All for One Steeb AG August 13, 2013

Highest single order in paragon s history

HAEMATO AG SOLID UPTICK IN H2 SALES AND EBIT MARGIN. FIRST BERLIN Equity Research PRICE TARGET H A

1 November 2017 M1 Kliniken AG. FIRST BERLIN Equity Research. Update following

BUY (previous: BUY) (previous: 75.65)

18 October 2016 aventron AG. FIRST BERLIN Equity Research

18 November 2016 Energiekontor AG. FIRST BERLIN Equity Research

Indygotech Minerals S.A.

14 September 2017 Pharming Group NV. FIRST BERLIN Equity Research. Update. Bloomberg: PHARM NA Return Potential 216.5% ISIN: NL

Geratherm Medical AG Strong demand in Q3

The growth story continues

Buy PT 24,00, upside 23%

Intershop Communications AG

Advanced Vision Technology

PNE WIND AG OFFSHORE PROJECT ATLANTIS I SOLD. FIRST BERLIN Equity Research. Good start to PRICE TARGET P N

27 March 2019 SFC Energy AG. FIRST BERLIN Equity Research. Final SUSTAINABLE MACRO TRENDS SUPPORT FUEL CELL BUSINESS

BUY (previous: BUY) (previous: 2.20)

17 May 2016 ISARIA Wohnbau AG. FIRST BERLIN Equity Research

BUY (previous: BUY) (previous: 3.40)

Advanced Vision Techn Buy

14 August 2017 PNE WIND AG. FIRST BERLIN Equity Research

18 January 2018 Pharming Group NV. FIRST BERLIN Equity Research. Update. Bloomberg: PHARM NA Return Potential 45.9% ISIN: NL

Leifheit AG. Management Meeting confirms our positive view. Buy (Buy) EUR (60.00 EUR ) BANKHAUS LAMPE // 1 16/02/2016

ad pepper media International N.V.

6 September 2016 aventron AG. FIRST BERLIN Equity Research

Tel.: +49 (0) Tel.: +49 (0)

5 September 2016 OTI Greentech AG. FIRST BERLIN Equity Research

BDI BioEnergy Internat Buy

24 May 2016 Energiekontor AG. FIRST BERLIN Equity Research

26 April 2017 aventron AG. FIRST BERLIN Equity Research

22 November 2017 Energiekontor AG. FIRST BERLIN Equity Research

HAEMATO AG MARKET SHARE WIN IN PARALLEL IMPORT BUSINESS. FIRST BERLIN Equity Research H1/18 PRICE TARGET H A

MATELAN Research. InVision 49.0 Buy. Excellent margin trend in Prelims. Update Note. 24 February Company / Sector Fair Value Recommendation

18 May 2018 Pharming Group NV. FIRST BERLIN Equity Research

24 September 2018 OpenLimit Holding AG. FIRST BERLIN Equity Research

11 January 2018 Deutsche Rohstoff AG. FIRST BERLIN Equity Research. Update. Bloomberg: DR0 GR Return Potential 40.2% ISIN: DE000A0XYG76

20 April 2018 Energiekontor AG. FIRST BERLIN Equity Research

Schloss Wachenheim AG

26 October 2017 Energiekontor AG. FIRST BERLIN Equity Research. Update. Bloomberg: EKT GR Return Potential 67.2% ISIN: DE

6 June 2018 Formycon AG. FIRST BERLIN Equity Research. Germany / Biopharmaceuticals Xetra Bloomberg: FYB GR Return Potential 44.2% ISIN: DE000A1EWVY8

19 December 2016 NOXXON Pharma NV. FIRST BERLIN Equity Research. Cooperation

14 November 2018 M1 Kliniken AG. FIRST BERLIN Equity Research. H1/18 figures &

EQUINET INVESTIGATOR

8 May 2018 Formycon AG. FIRST BERLIN Equity Research. Germany / Biopharmaceuticals Xetra Bloomberg: FYB GR Return Potential 36.3% ISIN: DE000A1EWVY8

27 February 2018 OpenLimit Holding AG. FIRST BERLIN Equity Research. Smart Meter Gateway BENEFITING FROM DIGITISATION OF HEALTH AND ENERGY MARKETS

Very solid Q3; excellent story, but priced in; TP upped to 60.00; downgrade to neutral. Q3 2016: Very solid quarter, better than expected

Aroundtown SA LATEST RUN RATES CONFIRM GROWTH PHASE. FIRST BERLIN Equity Research. Operational PRICE TARGET Ar ou

Adler Real Estate AG. Fewer vacancies, more properties. Buy (Buy) EUR (16.50 EUR ) BANKHAUS LAMPE // 1 28/03/2017

Net income (after min.) >100% EPS [ ] (0.63) (0.27) >100% 0.20 (1.85)

adesso AG MAY 31, 2012

16 April 2018 Epigenomics AG. FIRST BERLIN Equity Research. Update. Bloomberg: ECX Return Potential 96.9% ISIN: DE000A11QW50

Sandpiper Digital Payments AG

Almonty Industries inc.

Air France-KLM. Hold TP 6.50 CP 7.59 (Close 21 October 2013) Q3 due 31 October More restructuring needed. Equity Research Quick Bite Preview

Transcription:

Recommendation: BUY (BUY) Risk: HIGH (HIGH) Price Target: EUR 35.00 (35.00) 06 May 2013 New acquisition: ISRA acquires GP Solar GmbH What happened: ISRA VISION AG recently announced the acquisition of GP Solar GmbH and its subsidiary GP Inspect GmbH in Munich/Germany. GP Solar was part of the centrotherm photovoltaics Group responsible for inspection systems, process-specific materials and consulting services within the Group. GP Solar s inspection systems are integrated directly into the production lines and are specially developed to detect every kind of wafer defect. With its inspection systems the company addresses the end markets PV industry and semiconductors (i.e. was not the strategic focus in recent past) and has a particularly strong footprint in Asia. Details of the transaction: According to the company news, GP Solar is expected to generate revenues of EUR ~3.0m in 2013. However from midterm perspective we estimate the annual revenue potential of the company to range between EUR 5m - 7m once the PV equipment industry starts to recover. The purchase price contains a fixed price component in the amount of approx. 50 percent of the expected GP revenues for 2013 as well as an earn-out component based on sales units. ISRA expects to raise synergies from a potential restructuring and to monetize on GP Solar s strong sales organization in Asia. GP Solar has a global installation basis of ~1000 systems at leading Asian solar cell/module manufacturers. Change Share price (dark) vs TecDAX Sources: CBS Research AG, Bloomberg Internet: www. isravision.com WKN: 548810 Reuters: ISRG.DE Company profile: 11/12 12/13E 13/14E new old new old new old Sales - 83.9-91.8-100.8 EBIT - 15.6-17.5-20.0 EPS - 2.44-2.60-2.97 Sector: Technology ISIN: DE0005488100 Bloomberg: ISR GY Founded in 1985, ISRA VISION is a pioneer in Machine Vision (MV). Within the business divisions Surface Vision and Industrial Automation the company serves various market verticals. 2Q FY12/13E preview: Since ISRA will start consolidating GP Solar from May 2013 onwards, we think the impact on FY12/13E results (ending Sep. 2013) will be limited. Thus we leave our estimates unchanged for the time being and will update our estimates post 2Q FY12/13E results. ISRA is scheduled to release 2Q FY12/13E results on 31 May 2013. In the top line, we expect sales to amount to EUR 21.6m indicating a yoy/qoq increase of 14.6%/12.2%. On the operating level, we project a further improvement of the margins estimating EBIT of EUR 4.0m (EBIT margin of 19% vs 18.4% in 1Q FY12/13E). Considering the recent order announcement of EUR ~13m from a German car manufacturer, we expect order backlog to stabilize at EUR 50m mark, providing a sound visibility for the upcoming quarters. Share data: Share price (EUR, last closing price): Shares outstanding (in m): Market capitalisation (EURm): Enterprise value (EURm): Ø daily trading volume (3m., no. of shares): Performance data: High 52 weeks (EUR): Low 52 weeks (EUR): Absolute performance: (12 months) Relative performance (vs. TecDAX): 1 month 3 months 12 months 33.40 4.4 146.3 180.0 7,510 32.20 16.10 61.7% 7.2% 24.5% 33.9% Recommendation: We continue to rate ISRA VISION with a BUY recommendation and an unchanged price target of EUR 35.00/share. We think headlines will remain positive and believe there is still upside potential in the stock. Key data Y/E 30.09., EURm 09/10 10/11 11/12 12/13E 13/14E Sales 64.8 75.2 83.9 91.8 100.8 EBITDA 17.7 21.4 24.3 27.1 30.3 EBIT 11.5 14.1 15.6 17.5 20.0 Net income 7.0 9.1 10.7 11.4 13.0 EPS 1.62 2.09 2.44 2.60 2.97 DPS 0.15 0.20 0.25 0.30 0.30 EBITDA margin 27.2% 28.5% 28.9% 29.5% 30.1% EBIT margin 17.7% 18.8% 18.6% 19.0% 19.8% Net margin 10.7% 12.1% 12.7% 12.4% 12.9% EV/EBITDA 10.2 8.4 7.4 6.6 5.9 EV/EBIT 15.7 12.7 11.6 10.3 9.0 P/E 20.6 16.0 13.7 12.8 11.2 Source: Company Data, CBS Research AG Shareholders: Enis Ersü (CEO) Fidelity Vision GbR CI Investments DWS Investment Free float, others 25.2% 10.1% 5.0% 4.9% 3.1% 51.7% Financial calender: 1H FY11/12 results 31 May 2013 Author: Veysel Taze (Analyst) Close Brothers Seydler Research AG Phone: +49 (0)69-977 84 56 0 E-Mail: research@cbseydlerresearch.ag www.cbseydlerresearch.ag Please notice the information on the preparation of this document, the disclaimer, the advice regarding possible conflicts of interests, and the mandatory information required by 34b WpHG (Securities Trading Law) at the end of this document. This financial analysis in accordance with 34b WpHG is exclusively intended for distribution to individuals that buy or sell financial instruments at their own account or at the account of others in connection with their trading activities, occupation, or employment.

Income statement IFRS EURm 08/09 09/10 10/11 11/12 12/13E 13/14E Revenues 58.15 64.85 75.15 83.89 91.85 100.79 YoY grow th -14.8% 11.5% 15.9% 11.6% 9.5% 9.7% Cost of sales -28.17-30.52-34.93-38.61-42.25-46.06 Gross profit 29.99 34.33 40.22 45.27 49.60 54.73 as % of revenues 51.6% 52.9% 53.5% 54.0% 54.0% 54.3% Selling and Marketing expenses -10.27-11.52-13.69-15.51-16.07-17.24 as % of revenues -17.7% -17.8% -18.2% -18.5% -17.5% -17.1% Research and Development expenses -7.70-8.35-9.68-11.23-11.76-12.70 as % of revenues -13.2% -12.9% -12.9% -13.4% -12.8% -12.6% General and Administrative expenses -3.78-3.84-4.16-4.56-5.33-5.95 as % of revenues -6.5% -5.9% -5.5% -5.4% -5.8% -5.9% Other operating expenses/income 1.02 0.87 1.46 1.61 1.01 1.11 as % of revenues 1.8% 1.3% 1.9% 1.9% 1.1% 1.1% EBITDA 15.18 17.65 21.41 24.27 27.09 30.30 as % of revenues 26.1% 27.2% 28.5% 28.9% 29.5% 30.1% Depreciation and Amortization -5.92-6.17-7.27-8.70-9.64-10.34 as % of revenues -10.2% -9.5% -9.7% -10.4% -10.5% -10.3% EBIT 9.26 11.49 14.15 15.58 17.45 19.96 as % of revenues 15.9% 17.7% 18.8% 18.6% 19.0% 19.8% Net financial result -1.00-0.89-0.99-0.67-1.19-1.37 as % of revenues -1.7% -1.4% -1.3% -0.8% -1.3% -1.4% EBT 8.26 10.60 13.15 14.90 16.26 18.58 as % of revenues 14.2% 16.4% 17.5% 17.8% 17.7% 18.4% Income taxes -1.84-3.60-4.02-4.21-4.88-5.58 as % of EBT -22.3% -34.0% -30.5% -28.2% -30.0% -30.0% Net income 6.42 7.00 9.14 10.69 11.38 13.01 as % of revenues 11.0% 10.8% 12.2% 12.7% 12.4% 12.9% Minorities 0.05-0.05-0.07-0.03 0.00 0.00 Net income attributable to shareholders 6.47 6.95 9.07 10.66 11.38 13.01 as % of revenues 11.1% 10.7% 12.1% 12.7% 12.4% 12.9% Weight. Average of shares outstanding (in m) 4.26 4.30 4.34 4.37 4.37 4.37 Earnings per share 1.52 1.62 2.09 2.44 2.60 2.97 Source: ISRA Vision, CBS Research AG www.cbseydlerresearch.ag Close Brothers Seydler Research AG 2

Research Schillerstrasse 27-29 60313 Frankfurt am Main Phone: +49 (0)69 977 8456-0 Roger Peeters +49 (0)69-977 8456-12 Member of the Board Roger.Peeters@cbseydlerresearch.ag Martin Decot +49 (0)69-977 8456-13 Igor Kim +49 (0)69-977 8456-15 (Equities) Martin.Decot@cbseydlerresearch.ag (Equities) Igor.Kim@cbseydlerresearch.ag Anna von Klopmann +49 (0)69-977 8456-10 Gennadij Kremer +49 (0)69 977 8456-23 (Equities/Fixed Income) Anna.Klopmann@cbseydlerresearch.ag (Corporate Credit) Gennadij.Kremer@cbseydlerresearch.ag Daniel Kukalj +49 (0)69 977 8456-21 Ralf Marinoni +49 (0)69-977 8456-17 (Equities) Daniel.Kukalj@cbseydlerresearch.ag (Equities) Ralf.Marinoni@cbseydlerresearch.ag Manuel Martin +49 (0)69-977 8456-16 Felix Parmantier +49 (0)69-977 8456-22 (Equities) Manuel.Martin@cbseydlerresearch.ag (Equities) Felix.Parmantier@cbseydlerresearch.ag Nicolas Pütz +49 (0)69-977 8456-24 Marcus Silbe +49 (0)69-977 8456-14 (Support) Nicolas.Puetz@cbseydlerresearch.ag (Equities) Marcus.Silbe@cbseydlerresearch.ag Simone Steymann +49 (0)69-977 8456-25 Veysel Taze +49 (0)69-977 8456-18 (Support) Simone.Steymann@cbseydlerresearch.ag (Equities) Veysel.Taze@cbseydlerresearch.ag Ivo Višić +49 (0)69-977 8456-19 (Equities) Ivo.Visic@cbseydlerresearch.ag Institutional Sales Schillerstrasse 27 29 60313 Frankfurt am Main Phone: +49 (0)69 9 20 54-400 Klaus Korzilius +49 (0)69-9 20 54-114 Stefan Krewinkel +49 (0)69-9 20 54-118 (Benelux, Germany) Klaus.Korzilius@cbseydler.com (Sales Trading, Germany, UK) Stefan.Krewinkel@cbseydler.com Bruno de Lencquesaing +49 (0)69-9 20 54-116 Nico Gesthüsen +49 (0)69-9 20 54-115 (Benelux, France) Bruno.deLencquesaing@cbseydler.com (Germany) Nico.Gesthuesen@cbseydler.com Dr. James Jackson +49 (0)69-9 20 54-113 Claudia Jurewecz +49 (0)69-9 20 54-106 (UK) James.Jackson@cbseydler.com (Germany) Claudia.Jurewecz@cbseydler.com Markus Laifle +49 (0)69-9 20 54-120 Michael Laufenberg +49 (0)69-9 20 54-112 (Sales Trading, Execution) Markus.Laifle@cbseydler.com (Germany) Michael.Laufenberg@cbseydler.com Angela Leser +49 (0)69-9 20 54-111 Rasmus Mac Donald-Thomé +49 (0)69-9 20 54-119 (Germany) Angela.Leser@cbseydler.com (Scandinavia) Rasmus.MacDonald-Thomé@cbseydler.com Mirella Mancuso +49 (0)69-9 20 54-107 Zeljko Maric +49 (0)69-9 20 54-119 (Sales Support) Mirella.Mancuso@cbseydler.com (Scandinavia, Austria, East EU) Zeljko.Maric@cbseydler.com Carsten Pfersdorf +49 (0)69-9 20 54-168 Hugo Raffaitin +49 (0)69-9 20 54-102 (Sales Trading, Execution) Carsten.Pfersdorf@cbseydler.com (Sales Support) Hugo.Raffaitin@cbseydler.com Carsten Schlegel +49 (0)69-9 20 54-137 Christopher Seedorf +49 (0)69-9 20 54-110 (UK, Ireland) Carsten.Schlegel@cbseydler.com (Sales Support) Christopher.Seedorf@cbseydler.com Holger Schmidt +49 (0)69-9 20 54-103 Bas-Jan Walhof +49 (0)69-9 20 54-105 (UK) Holger.Schmidt@cbseydler.com (Benelux) Bas-Jan.Walhof@cbseydler.com www.cbseydlerresearch.ag Close Brothers Seydler Research AG 3

Disclaimer and statement according to 34b German Securities Trading Act ( Wertpapierhandelsgesetz ) in combination with the provisions on financial analysis ( Finanzanalyseverordnung FinAnV) This report has been prepared independently of the company analysed by Close Brothers Seydler Research AG and/ or its cooperation partners and the analyst(s) mentioned on the front page (hereafter all are jointly and/or individually called the author ). None of Close Brothers Seydler Research AG, Close Brothers Seydler Bank AG or its cooperation partners, the Company or its shareholders has independently verified any of the information given in this document. Section 34b of the German Securities Trading Act in combination with the FinAnV requires an enterprise preparing a security analysis to point out possible conflicts of interest with respect to the company that is the subject of the analysis. Close Brothers Seydler Research AG is a majority owned subsidiary of Close Brothers Seydler Bank AG (hereafter CBS ). However, Close Brothers Seydler Research AG (hereafter CBSR ) provides its research work independent from CBS. CBS is offering a wide range of Services not only including investment banking services and liquidity providing services (designated sponsoring). CBS or CBSR may possess relations to the covered companies as follows (additional information and disclosures will be made available upon request): a. CBS holds more than 5% interest in the capital stock of the company that is subject of the analysis. b. CBS was a participant in the management of a (co)consortium in a selling agent function for the issuance of financial instruments, which themselves or their issuer is the subject of this financial analysis within the last twelve months. c. CBS has provided investment banking and/or consulting services during the last 12 months for the company analysed for which compensation has been or will be paid for. d. CBS acts as designated sponsor for the company's securities on the basis of an existing designated sponsorship contract. The services include the provision of bid and ask offers. Due to the designated sponsoring service agreement CBS may regularly possess shares of the company and receives a compensation and/ or provision for its services. e. The designated sponsor service agreement includes a contractually agreed provision for research services. f. CBSR and the analysed company have a contractual agreement about the preparation of research reports. CBSR receives a compensation in return. g. CBS has a significant financial interest in relation to the company that is subject of this analysis. In this report, the following conflicts of interests are given at the time, when the report has been published: d, f CBS and/or its employees or clients may take positions in, and may make purchases and/ or sales as principal or agent in the securities or related financial instruments discussed in this analysis. CBS may provide investment banking, consulting, and/ or other services to and/ or serve as directors of the companies referred to in this analysis. No part of the authors compensation was, is or will be directly or indirectly related to the recommendations or views expressed. Recommendation System: Close Brothers Seydler Research AG uses a 3-level absolute share rating system. The ratings pertain to a time horizon of up to 12 months: BUY: The expected performance of the share price is above +10%. HOLD: The expected performance of the share price is between 0% and +10%. SELL: The expected performance of the share price is below 0%. Recommendation history over the last 12 months for the company analysed in this report: Date Recommendation Price at change date Price target 06 May 2013 BUY EUR 33.40 EUR 35.00 01 March 2013 BUY EUR 31.73 EUR 35.00 14 December 2012 BUY EUR 24.20 EUR 28.00 12 December 2012 BUY EUR 24.10 EUR 28.00 04 September 2012 BUY EUR 20.09 EUR 24.00 www.cbseydlerresearch.ag Close Brothers Seydler Research AG 4

29 August 2012 BUY EUR 20.19 EUR 24.00 31 May 2012 BUY EUR 17.90 EUR 24.00 Risk-scaling System: Close Brothers Seydler Research AG uses a 3-level risk-scaling system. The ratings pertain to a time horizon of up to 12 months: LOW: The volatility is expected to be lower than the volatility of the benchmark MEDIUM: The volatility is expected to be equal to the volatility of the benchmark HIGH: The volatility is expected to be higher than the volatility of the benchmark The following valuation methods are used when valuing companies: Multiplier models (price/earnings, price/cash flow, price/book value, EV/Sales, EV/EBIT, EV/EBITA, EV/EBITDA), peer group comparisons, historical valuation approaches, discounting models (DCF, DDM), break-up value approaches or asset valuation approaches. The valuation models are dependent upon macroeconomic measures such as interest, currencies, raw materials and assumptions concerning the economy. In addition, market moods influence the valuation of companies. The figures taken from the income statement, the cash flow statement and the balance sheet upon which the evaluation of companies is based are estimates referring to given dates and therefore subject to risks. These may change at any time without prior notice. The opinions and forecasts contained in this report are those of the author alone. Material sources of information for preparing this report are publications in domestic and foreign media such as information services (including but not limited to Reuters, VWD, Bloomberg, DPA-AFX), business press (including but not limited to Börsenzeitung, Handelsblatt, Frankfurter Allgemeine Zeitung, Financial Times), professional publications, published statistics, rating agencies as well as publications of the analysed issuers. Furthermore, discussions were held with the management for the purpose of preparing the analysis. Potentially parts of the analysis have been provided to the issuer prior to going to press; no significant changes were made afterwards, however. Any information in this report is based on data considered to be reliable, but no representations or guarantees are made by the author with regard to the accuracy or completeness of the data. The opinions and estimates contained herein constitute our best judgment at this date and time, and are subject to change without notice. Possible errors or incompleteness of the information do not constitute grounds for liability, neither with regard to indirect nor to direct or consequential damages. The views presented on the covered company accurately reflect the personal views of the author. All employees of the author's company who are involved with the preparation and/or the offering of financial analyzes are subject to internal compliance regulations. The report is for information purposes, it is not intended to be and should not be construed as a recommendation, offer or solicitation to acquire, or dispose of, any of the securities mentioned in this report. Any reference to past performance should not be taken as indication of future performance. The author does not accept any liability whatsoever for any direct or consequential loss arising from any use of material contained in this report. The report is confidential and it is submitted to selected recipients only. The report is prepared for professional investors only and it is not intended for private investors. Consequently, it should not be distributed to any such persons. Also, the report may be communicated electronically before physical copies are available. It may not be reproduced (in whole or in part) to any other investment firm or any other individual person without the prior written approval from the author. The author is not registered in the United Kingdom nor with any U.S. regulatory body. It has not been determined in advance whether and in what intervals this report will be updated. Unless otherwise stated current prices refer to the closing price of the previous trading day. Any reference to past performance should not be taken as indication of future performance. The author maintains the right to change his opinions without notice, i.e. the opinions given reflect the author s judgment on the date of this report. This analysis is intended to provide information to assist institutional investors in making their own investment decisions, not to provide investment advice to any specific investor. By accepting this report the recipient accepts that the above restrictions are binding. German law shall be applicable and court of jurisdiction for all disputes shall be Frankfurt am Main (Germany). This report should be made available in the United States solely to investors that are (i) "major US institutional investors" (within the meaning of SEC Rule 15a-6 and applicable interpretations relating thereto) that are also "qualified institutional buyers" (QIBs) within the meaning of SEC Rule 144A promulgated by the United States Securities and Exchange Commission pursuant to the Securities Act of 1933, as amended (the "Securities Act") or (ii) investors that are not "US Persons" within the meaning of Regulation S under the Securities Act and applicable interpretations relating thereto. The offer or sale of certain securities in the United States may be made to QIBs in reliance on Rule 144A. Such securities may include those offered and sold outside the United States in transactions intended to be exempt from registration pursuant to Regulation S. This report does not constitute in any way an offer or a solicitation of interest in any securities to be offered or sold pursuant to Regulation S. Any such securities may not be offered or sold to US Persons at this time and may be resold to US Persons only if such securities are registered under the Securities Act of 1933, as amended, and applicable state securities laws, or pursuant to an www.cbseydlerresearch.ag Close Brothers Seydler Research AG 5

exemption from registration. This publication is for distribution in or from the United Kingdom only to persons who are authorised persons or exempted persons within the meaning of the Financial Services and Markets Act 2000 of the United Kingdom or any order made there under or to investment professionals as defined in Section 19 of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and is not intended to be distributed or passed on, directly or indirectly, to any other class of persons. This publication is for distribution in Canada only to pension funds, mutual funds, banks, asset managers and insurance companies. The distribution of this publication in other jurisdictions may be restricted by law, and persons into whose possession this publication comes should inform themselves about, and observe, any such restrictions. In particular this publication may not be sent into or distributed, directly or indirectly, in Japan or to any resident thereof. Responsible Supervisory Authority: Bundesanstalt für Finanzdienstleistungsaufsicht (BaFin, Federal Financial Supervisory Authority) Graurheindorferstraße 108 53117 Bonn and Lurgiallee 12 60439 Frankfurt Schillerstrasse 27-29 60313 Frankfurt am Main www.cbseydlerresearch.ag Tel.: 0049 - (0)69-97 78 45 60 www.cbseydlerresearch.ag Close Brothers Seydler Research AG 6